Cardinal Health, Inc.

New York Stock Exchange
Back to all articles
Bullish +62

Cardinal Health, Inc. $CAH Shares Purchased by Assetmark Inc.

AI-generated analysis

📈 Assetmark Inc. boosted its Cardinal Health holdings by 35.4% in Q1, adding 27,631 shares to a total position of 105,770 shares.

💰 Institutional investors including Aventura Private Wealth LLC and University of Texas Texas AM Investment Management Co. acquired new stakes valued at approximately $25,000-$29,000 each.

📊 Cardinal Health stock trades at a market cap of $53.53 billion with a P/E ratio of 34.95 and a beta of 0.49.

💵 The company paid a quarterly dividend of $0.5158 on July 15th, raising the annualized yield to 0.9% from the previous 0.87%.

📈 Morgan Stanley raised its price target to $255.00 and maintained an 'overweight' rating on the stock.

📉 Zacks Research downgraded Cardinal Health from a 'strong-buy' to a 'hold' rating in late June.

🏥 Cardinal Health provides wholesale distribution of pharmaceuticals and medical-surgical products to healthcare providers.

🎯 Analyst consensus is a 'Moderate Buy' with an average target price of $249.13 based on data from MarketBeat.

Bullish Signals
  • Assetmark Inc. significantly increased its stake in Cardinal Health by 35.4% in the first quarter, indicating institutional confidence.
  • Multiple new institutional investors entered positions in Q4 and Q1, including Aventura Private Wealth LLC and Indiana Trust & Investment Management Co.
  • Morgan Stanley raised its price target to $255.00 and reaffirmed an 'overweight' rating on the stock.
  • Bank of America increased its price objective to $260.00 and maintained a 'buy' rating.
  • Citigroup reiterated its 'buy' rating on Cardinal Health shares.
  • William Blair initiated coverage with an 'outperform' rating, adding to the bullish analyst consensus.
  • The company increased its quarterly dividend from $0.51 to $0.5158, reflecting a commitment to shareholder returns.
  • Fifteen analysts rate the stock as a Buy compared to only three Hold ratings.
Risk Factors
  • Zacks Research downgraded Cardinal Health from a 'strong-buy' to a 'hold' rating in late June.
  • The stock has a high P/E ratio of 34.95, which may suggest the market is pricing in significant future growth.
Full Analysis
Assetmark Inc. increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 35.4% during the first quarter, purchasing an additional 27,631 shares to reach a total of 105,770 shares valued at $22.35 million. Several other institutional investors and hedge funds also adjusted their stakes in the company during the fourth and first quarters, with new positions acquired by Aventura Private Wealth LLC, University of Texas Texas AM Investment Management Co., Bank of Jackson Hole Trust, Indiana Trust & Investment Management Co., and Palladiem LLC. Cardinal Health's stock opened at $228.57 on Friday, trading within a fifty-two-week range of $137.75 to $243.21. The company has a market capitalization of $53.53 billion and a P/E ratio of 34.95. Recently, the firm announced a quarterly dividend of $0.5158 per share, paid on July 15th to investors of record from July 1st, representing an annualized yield of 0.9% and a payout ratio of 31.50%. Analyst sentiment remains mixed but generally positive regarding the stock's valuation and outlook. Morgan Stanley raised its target price to $255.00 with an 'overweight' rating, while Bank of America increased its objective to $260.00 with a 'buy' rating. Conversely, Zacks Research downgraded the stock from 'strong-buy' to 'hold'. The consensus among fifteen analysts is a 'Moderate Buy' with an average target price of $249.13. Headquartered in Dublin, Ohio, Cardinal Health operates as a multinational healthcare services and products company established in the early 1970s. It serves hospitals, health systems, pharmacies, physician offices, and clinical laboratories through wholesale distribution of pharmaceuticals, supply of medical-surgical products, and logistics solutions.